Presentation
An 89-year-old male with a significant history of urological disease initially presented to Memorial Sloan Kettering Cancer Center in 2020 for management of metastatic castrate-resistant prostate cancer (mCRPC). In 2025, he developed urinary incontinence due to erosion of a previously placed artificial urinary sphincter (AUS). A nephrostomy catheter was subsequently placed, during which multiple urine cultures revealed multidrug-resistant organisms.
Did You Guess the Diagnosis?
Watch the video below to learn the answer!
Author Information
Tomas Bermudez, Ph.D., 91麻豆精品CPEP Clinical and Public Health Microbiology Fellow, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center.
Stay up to date on all 91麻豆精品Clinical Public Health Microbiology (CPHM) activities when you sign up for our monthly CPHM Newsletter. Be the first to know about free educational webinars, continuing education credit opportunities, advocacy, updated guidelines and more.